-
After Colorectal Cancer, Survivors Face Higher Risk for a Second CancerResearchers find increased risk of four types of secondary cancer in patients diagnosed with early-onset colorectal cancer.
by Sandra Gordon
-
Sunscreen Is Just the StartExperts say protection against UV rays and watching for changes in your skin are important tools in skin cancer risk prevention.
by Kyle Bagenstose
-
From the Editor-in-Chief
Artificial IntelligenceAI has significant implications for medicine, especially for precision cancer care.
by William G. Nelson, MD, PhD
-
Ovarian Cancer: A Quest to Extend RemissionsNew treatments aim to lengthen remissions and push back recurrences.
by Erin O’Donnell
-
ADCs Make Their MarkAntibody-drug conjugates link a targeted medication with a toxic drug to deliver a potent payload inside cancer cells.
by Kendall K. Morgan
-
Healthy Habits
Not So SweetDrinking sugar-sweetened beverages contributes to excess body fat and increased risk for certain cancers.
by Anne Danahy
-
Healthy Habits
Preventing Nerve DamageNew research suggests compression and cold therapy may limit chemotherapy-induced peripheral neuropathy.
by Tyler Santora
-
Forward Look
Bispecific Antibodies to Treat CancerHematologist-oncologist Saad Usmani talks about recent approvals for bispecific antibodies to treat multiple myeloma and other blood cancers.
by Ashley P. Taylor
-
Forward Look
New Hormonal Therapy Pill for Advanced Breast CancerNew oral hormonal therapy offers alternative to injections for some women with metastatic disease.
by Kris Conner
-
Forward Look
Tumor-infiltrating LymphocytesAdoptive T-cell therapy shows promise in treating metastatic melanoma.
by Marci A. Landsmann
Reports on breast density inform women of their status but raise questions about what to do next.
by Robin Roenker
Injection Immunotherapies Get FDA ApprovalGiving immunotherapy drugs as injections, rather than intravenously, means patients can spend less time in the hospital or treatment center.
by Laura Gesualdi-Gilmore
Designing Clinical Trials for the PatientChallenges in developing and studying treatments call for new ways of thinking about cancer research.
by Eric Fitzsimmons
Treating Smoldering Multiple MyelomaA monoclonal antibody drug reduced the risk of smoldering myeloma progressing to multiple myeloma in patients at high risk for disease progression.
by Sandra Gordon
-
AACR IO: Revolutionizing Treatment through ImmunotherapyThe AACR’s immuno-oncology meeting brings together the leading experts in immunotherapy to accelerate progress in cancer science and medicine.
-
A New Resource Provides a Sanctuary for Black TNBC PatientsThe Black TNBC Sanctuary was created to help Black women with triple-negative breast cancer get answers about their diagnosis and care.
Dr. Humberto M. Guiot: Targeting Pancreatic Cancer in a Community-Based Clinical Trial
